Furthermore, p53-related markers are detectable across the premalignant to malignant progression spectrum; both tissue p53 immunoreactivity and circulating serum anti-p53 antibodies occur in oral potentially malignant disorders (OPMDs), such as leukoplakia lesions, and in OSCC. Here, TP53 is linked to Oral leukoplakia.